CX3CR1 and neoplasm: Finally, we sorted the lung tumor-infiltrated MHC-IIhigh and MHC-IIlow TAMs and Ly6C+ inflammatory and CX3CR1+ residential monocytes from 3-week LLC-engrafted mice to evaluate their capacity to boost LLC target cell-specific killing ex vivo (Figures 3E, F).